Fig. 2: RP11-544M22.13 Promotes DDP resistance and oncological behavior in NSCLC. | Cell Death Discovery

Fig. 2: RP11-544M22.13 Promotes DDP resistance and oncological behavior in NSCLC.

From: A novel lncRNA RP11-544M22.13 enhances glycolysis-induced cisplatin resistance in non-small cell lung cancer

Fig. 2

All NSCLC cells were treated with 1 μg/ml DDP. A Expression of RP11-544M22.13 in DDP-resistant NSCLC cell lines. B, C Construction of DDP-resistant NSCLC cell lines. D Detection of DDP sensitivity of RP11-544M22.13 knockdown NSCLC cells (E) Detection of DDP sensitivity of RP11-544M22.13 overexpression NSCLC cells. F Detection of the proliferation ability of RP11-544M22.13 knockdown NSCLC cells by CCK8 assay. G Detection of the proliferation ability of RP11-544M22.13 overexpression NSCLC cells by CCK8 assay. H The proliferation ability of RP11-544M22.13 knockdown NSCLC cells was detected by colony formation assay. I The proliferation ability of RP11-544M22.13 overexpressing NSCLC cells was detected by colony formation assay. J The migration ability of RP11-544M22.13 knockdown NSCLC cells was detected by scratch assay. K The migration ability of RP11-544M22.13 overexpression NSCLC cells was detected by scratch assay. L By Transwell Experiment to detect the invasive ability of RP11-544M22.13 knockdown NSCLC cells. M Transwell assay to detect the invasive ability of RP11-544M22.13 overexpressing NSCLC cells.

Back to article page